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Effect of hyperparathyroidism on arterial distensibility in renal trans-
plant recipients.
Background. The cushioning function of the arterial system is altered in
patients with end-stage renal failure. The role of hyperparathyroidism for
the altered vessel wall properties of large arteries is not known.
Methods. To exclude the confounding effects of fluid volume changes
and hypercirculation as well as uremic toxicity on vessel wall properties
from those of hyperparathyroidism, the present study was conducted in 54
normotensive renal transplant recipients with good graft function, three to
six months after transplantation. The vessel wall properties of the common
carotid artery were investigated in 32 of them, who had increased plasma
intact parathyroid hormone (iPTH) levels (136 6 12 ng/liter, SEM), and
compared to those of 22 control recipients of same age with normal
plasma iPTH levels (34 6 4 ng/liter). Arterial distension was measured by
Doppler analysis of the vessel wall movements, blood pressure was
determined by sphygmomanometry.
Results. Blood pressure was 140 6 3/85 6 2 mm Hg in renal transplant
recipients with hyperparathyroidism, 135 6 3/83 6 1 mm Hg in patients
with normal plasma iPTH levels (NS). There was no difference in
enddiastolic diameter of the common carotid artery (7.4 6 0.2 mm) in
renal transplant recipients with hyperparathyroidism as compared with the
control patients (7.3 6 0.2 mm; NS). Renal transplant recipients with
hyperparathyroidism had a lower distension (389 6 27 mm vs. 468 6 28
mm, P , 0.05) and distensibility coefficient of the common carotid artery
(15.1 6 1.1 1023/kPa vs. DC 19.0 6 1.0 1023/kPa, P , 0.01) when
compared with the control patients. Multiple regression analysis showed
that the distensibility coefficient of the common carotid artery was
negatively correlated with age (P , 0.001), mean arterial blood pressure
(P , 0.05) and plasma iPTH levels (P , 0.05). The effects of plasma iPTH
levels were not related to serum calcium concentrations or to differences
in the enddiastolic diameter of the common carotid artery.
Conclusions. The data suggest that secondary hyperparathyroidism can
affect the cushioning function of larger arteries in patients with end-stage
renal failure independently of high blood pressure.
Cardiovascular disease is a major cause of morbidity and
mortality in patients with end-stage renal failure [1–3].
During the last years it became obvious that cardiovascular
disease can be related to disorders affecting the cushioning
function of the arterial system [1, 4]. Alterations of the
cushioning function by arterial stiffening are associated
with increased systolic and pulse pressures, increased load
imposed on the left ventricle and a reduction in subendo-
cardial coronary blood supply during diastole [1, 4, 5]. In
hypertensive patients with normal kidney function, a de-
creased arterial compliance was found independent of the
actual blood pressure levels [6, 7]. Several studies have
shown that the viscoelastic properties of the arterial system
are greatly disturbed in experimental uremia as well as in
patients maintained by chronic hemodialysis or after renal
transplantation [8–11].
The mechanism(s) responsible for arterial stiffening in
end-stage renal failure are not known. Apart from high
blood pressure, changes of fluid volume and hypercircula-
tion related to arteriovenous fistula and anemia, uremic
toxic effects, and hyperparathyroidism also may affect the
viscoelastic properties of larger arteries. Duprez et al have
recently shown a significant correlation between parathy-
roid hormone levels and the distensibility of the common
carotid artery in essential hypertensive patients [12]. How-
ever, until now there have been no data on the role of
hyperparathyroidism for the cushioning function of the
arterial system in end-stage renal failure and after renal
transplantation. The present study, therefore, aimed to
compare the vessel wall properties in patients with hyper-
parathyroidism and in patients with no evidence of a
disturbed calcium and phosphate metabolism. To discrim-
inate the effects of fluid volume changes and hypercircula-
tion as well as uremic toxicity on vessel wall properties from
those of hyperparathyroidism, the present study was con-
ducted in normotensive renal transplant recipients with
good renal function, three to six months after renal trans-
plantation.
METHODS
Our study was performed in accordance with protocols
approved by the local ethics committee at the University of
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Mu¨nster. Fifty-four renal transplant recipients were in-
cluded in this study, and each subject gave informed
consent to participate. The patients entered the study three
to six months after renal transplantation (range 103 to 181
days). The following exclusion criteria were used: coronary
artery disease, heart failure, valvular heart disease, cerebral
vascular disease, peripheral artery disease or diabetes
mellitus. All patients had blood pressure levels at or below
160/90 mm Hg at the time of investigation. Apart from
diuretic therapy, the patients were not on antihypertensive
drugs. During hemodialysis therapy prior to transplanta-
tion, blood pressure levels were at or below 160/90 mm Hg
without antihypertensive treatment. Renal transplant func-
tion was stable for at least six weeks and serum creatinine
levels were below 2.5 mg/dl in all patients. Immunosuppres-
sive treatment consisted of cyclosporine and prednisolone
(5 to 15 mg/day). Cyclosporine whole blood trough levels
were individually adjusted to 100 to 150 ng/ml by the high
pressure liquid chromatography (HPLC) method. Blood
was drawn while the patient was in a fasting state in the
morning for routine laboratory analysis that included total
serum calcium, serum phosphate, total serum protein level
and serum protein electrophoresis. To assess the concen-
tration of ionized serum calcium, percentage of calcium
bound to serum protein was estimated according to the
formula: percent protein bound calcium 5 8 3 albumin
(g/dl) 1 2 3 globulin (g/dl) 1 3. Ionized serum calcium
level was calculated by subtracting protein bound from
total serum calcium level. Plasma intact (1-84) parathyroid
hormone (iPTH) concentrations were determined using an
radioimmunoassay. The reference values for this assay are
12 to 65 ng/liter. Thirty-two renal transplant recipients with
increased plasma iPTH levels were considered to have
secondary hyperparathyroidism. Twenty-two renal trans-
plant recipients with normal plasma iPTH levels and no
evidence of disturbed calcium and phosphate metabolism
in their medical history were included into the study as
controls. The clinical and biochemical characteristics are
shown in Tables 1 and 2.
Following blood sampling and routine clinical examina-
tion, vessel wall properties of the common carotid artery
were studied in the morning. After subjects had rested for
10 minutes in the supine position, the left common carotid
artery was studied 2 cm below the bifurcation in a longitu-
dinal projection with a multigate pulsed Doppler system
(Cardiovascular Research Institute, Maastricht, The Neth-
erlands) [13, 14]. The probe was placed rectangularly on
the vessel. In the multigate system, 64 sample volumes were
spaced at 0.5 mm intervals. The observation range of 32
mm was sufficient for investigation of the carotid artery.
Changes in vessel wall position could be monitored based
on the low-frequency Doppler signals originating from the
sample volumes coinciding with the arterior and posterior
walls. The positions of the sample volumes were continu-
ously adjusted according to the displacement of the wall.
The Doppler signals in M-mode were temporarily stored
and analyzed by a personal computer. The resolution for a
6.1-Mhz Doppler system was equivalent to a displacement
of 31,25 mm (assuming a speed of sound of 1525 m/second),
Table 1. Clinical characteristics of renal transplant recipients with
increased plasma iPTH levels (N 5 32) and with normal plasma iPTH
levels (N 5 22)
Patients
with normal
iPTH levels
(N 5 22)
Patients with
increased
iPTH levels
(N 5 32) P
Age years 41 6 3 44 6 2 NS
Female/male 12/10 18/14 NS
Body mass index kg/m2 21.5 6 0.5 22.4 6 0.6 NS
Time after
transplantation days
121 6 6 130 6 7 NS
Total dose of
prednisolon g
3.07 6 0.24 3.34 6 0.19 NS
Cyclosporine dose
mg/day
244 6 19 262 6 14 NS
Hemodialysis period
months
27 6 3 34 6 3 NS
Duration of hypertension
prior hemodialysis
months
39 6 16 45 6 12 NS
Number of patients
receiving calcitriol
prior to
transplantation
14 (64%) 24 (75%) NS
Number of patients
receiving CaCo3 prior
to transplantation
18 (82%) 22 (69%) NS
Data represent mean 6 SEM. Abbreviation iPTH is intact parathyroid
hormone.
Table 2. Biochemical characteristics of renal transplant recipients with
increased plasma iPTH levels (N 5 32) and with normal plasma iPTH
levels (N 5 22)
Patients
with normal
iPTH levels
(N 5 22)
Patients with
increased
iPTH levels
(N 5 32) P
Parathyroid hormone level
ng/liter
34 6 4 136 6 12 , 0.001
Serum calcium level
mmol/liter
2.48 6 0.04 2.56 6 0.03 NS
Total serum protein level
g/dl
6.94 6 0.08 6.83 6 0.09 NS
Serum albumin level g/dl 4.52 6 0.09 4.46 6 0.07 NS
Ionized serum calcium level
mmol/liter
1.39 6 0.02 1.45 6 0.02 , 0.05
Serum phosphate level mg/dl 2.9 6 0.1 2.7 6 0.1 NS
Serum alkaline phosphatase
U/liter
156 6 20 179 6 20 NS
Blood hemoglobin level
g/liter
11.3 6 0.4 10.1 6 0.3 , 0.05
Serum creatinine level mg/dl 1.7 6 0.1 1.6 6 0.1 NS
Total serum cholesterol level
mg/dl
256 6 8 244 6 12 NS
Cyclosporine trough blood
level ng/ml
97 6 15 90 6 7 NS
Data represent mean 6 SEM. Abbreviation iPTH is intact parathyroid
hormone.
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which far exceeds the resolution capacity of a real-time
scanner for static objects. Since both the recorded changes
in diameter and the initial diameter similarly depended on
the angle of observation, the ratio of both will be angle
independent. The system allows the assessment of the
relative change of major peripheral arteries as a continuous
function of time with an accuracy of about 0.5%. Blood
pressure measurements were based on three independent
readings after the subjects rested in supine position for at
least 10 minutes. Blood pressure was determined on the
arm without arteriovenous fistula by sphygmomanometry
before ultrasonographic assessment. The phase I and V of
Korotkoff sounds were taken as the systolic and diastolic
blood pressures (SBP, DBP), respectively. Cuffs were
adapted to arm circumference. With this non-invasive
technique, the end-diastolic diameter [d (mm)], and systolic
increase of vessel diameter [distension, Dd (mm)] were
measured. From these data and from the systolic and
diastolic blood pressure, the relative systolic increase of
vessel diameter [(Dd 3 d21 (%)] and the arterial wall
distensibility coefficient [DC 5 Dd 3 d21/(SBP 2 DBP)
(1023/kPa)] were calculated [13, 14]. The coefficients of
variation were 3.4% for end-diastolic diameter, 7.4% for
the relative systolic increase of vessel diameter and 10.8%
for the distensibility coefficient (N 5 15).
Statistics
Statistical analysis was performed using the computer
software SPSS (Statistical Package of Social Science, 4.0,
1990; SPSS Inc., Chicago, IL, USA). Data were expressed
as mean 6 SEM. Student’s t-test was used to assess the
significance of continuous variables and the chi-square test
for qualitative variables. Values of P , 0.05 were consid-
ered to be statistically significant. Stepwise multiple regres-
sion analysis was used to assess the independent relations
between vessel wall parameters and plasma iPTH levels.
The multivariate statistical model was used to select for the
final multiple regression model only factors that correlated
with the distensibility coefficient or the end diastolic diam-
eter of the common carotid artery at a level of significance
of , 0.1.
RESULT
The group of renal transplant recipients with increased
plasma iPTH levels and with normal plasma iPTH levels
did not differ in age, gender and body mass index (Table 1).
The time after transplantation, total dose of prednisolone
and cyclosporine, duration of hypertension prior to hemo-
dialysis therapy and duration of the hemodialysis period
were not significantly different between renal transplant
recipients with increased plasma iPTH levels and the
control patients. This was also true for the number of
patients, who were treated with calcitriol or CaCO3 prior
transplantation (Table 1). Renal transplant function indi-
cated by serum creatinine, serum calcium, total serum
protein, serum phosphate, cyclosporine trough blood levels
as well as total serum cholesterol levels were similar in both
study groups (Table 2). In the renal transplant recipients
with increased plasma iPTH levels, ionized serum calcium
level was significantly higher, blood hemoglobin concentra-
tion significantly lower than in patients with normal plasma
iPTH levels (Table 2).
Systolic and diastolic blood pressure levels were not
significantly different between renal transplant recipients
with increased and with normal plasma iPTH levels (Table
3). The end diastolic diameter of the common carotid
artery also did not differ between both study groups. In
contrast, the absolute and relative distensions of the com-
mon carotid artery were significantly lower in renal trans-
plant recipients with increased iPTH levels than in the
control patients. The distensibility coefficient of the com-
mon carotid artery was also significantly decreased in renal
transplant recipients with increased plasma iPTH levels
(Fig. 1).
Multiple regression analysis in renal transplant recipients
with normal and increased plasma iPTH levels showed that
the distensibility coefficient of the common carotid artery
was negatively correlated with age (P , 0.005) and with
mean arterial blood pressure (P , 0.05; Table 4). There
was also a significant and independent negative relation-
ship between the distensibility coefficent of the common
carotid artery and plasma iPTH levels (P , 0.03; Fig. 2). No
significant relationships were found between the distensi-
bility coefficient and serum calcium, ionized serum calcium,
serum creatinine and blood hemoglobin concentrations
(Table 4). The distensibility coefficient of the common
carotid artery was also not related to the duration of
hypertension prior hemodialysis therapy, the hemodialysis
period and the body mass index (Table 4).
There was a significant relationship between the end
diastolic diameter of the common carotid artery and age in
the multiple regression analysis (P , 0.001). A significant
Table 3. Systolic and diastolic blood pressure and vessel parameter of
the common carotid artery in renal transplant recipients with increased
plasma iPTH levels (N 5 32) and with normal plasma iPTH levels
(N 5 22)
Patients
with normal
iPTH levels
(N 5 22)
Patients with
increased
iPTH levels
(N 5 32) P
Systolic blood pressure
mm Hg
135 6 3 140 6 3 NS
Diastolic blood
pressure mm Hg
83 6 1 85 6 2 NS
End diastolic diameter
mm
7.3 6 0.2 7.4 6 0.2 NS
Distension mm 468 6 28 389 6 27 , 0.05
Relative distension % 6.4 6 0.4 5.4 6 0.4 , 0.05
Distensibility coefficient
1023/kPa
19.0 6 1.0 15.1 6 1.1 , 0.01
Data represent mean 6 SEM.
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correlation was also observed between the end diastolic
diameter and serum creatinine levels (P , 0.02; Table 5).
In contrast to the significant correlation between the dis-
tensibility coefficient of the common carotid artery and
plasma iPTH levels, the end diastolic diameter was not
related to plasma iPTH levels. Moreover, no relationship
was found between the end diastolic diameter of the
common carotid artery and serum calcium, ionized serum
calcium as well as blood hemoglobin concentrations. This
was also true for the relationships between the end diastolic
diameter and mean arterial pressure, body mass index,
duration of hypertension prior to hemodialysis therapy as
well as duration of the hemodialysis period (Table 5).
DISCUSSION
The present study evaluated the effects of plasma iPTH
levels on the viscoelastic properties of large arteries. The
data show that the distensibility of the common carotid
artery is significantly decreased in renal transplant recipi-
ents with increased plasma iPTH levels as compared to
renal transplant recipients with normal plasma iPTH levels.
There was a significant negative correlation between the
distensibility of the common carotid artery and plasma
iPTH concentrations. The effects of plasma iPTH levels
were not related to serum calcium concentrations, blood
pressure levels or history of hypertension and were not due
to differences in the end diastolic diameter of the common
carotid artery. The data suggest that secondary hyperpara-
thyroidism can affect the cushioning function of larger
arteries in patients with end-stage renal failure.
In hemodialysis patients and in renal transplant recipi-
ents reduced arterial distensibility was associated with an
Fig. 1. Distensibility coefficient of the common carotid artery in renal
transplant recipients with increased plasma intact parathyroid hormone
(iPTH) levels (N 5 32) and with normal plasma iPTH levels (N 5 22).
Table 4. Stepwise multiple regression analysis between the distensibility
coefficient of the common carotid artery (dependent variable) and age,
mean arterial blood pressure, plasma iPTH, serum calcium, ionized
serum calcium, serum creatinine, blood hemoglobin levels, body mass
index, duration of hypertension prior to hemodialysis therapy as well as
the hemodialysis period (independent variables) in renal transplant
recipients (N 5 54)
Parameters dependent variable:
distensibility coefficient b P value
Variables in the equation
Age 20.39 0.0021
Parathyroid hormone level 20.27 0.0282
Mean arterial pressure 20.25 0.0492
Duration of hypertension prior to
hemodialysis therapy
20.21 0.0940
Variables not in the equation
Serum calcium level 0 0.8907
Ionized serum calcium level 0 0.8776
Serum creatinine level 0 0.6389
Blood hemoglobin level 0 0.9947
Body mass index 0 0.4440
Hemodialysis period 0 0.4661
Beta is standard regression coefficient.
Fig. 2. Relationship between between the distensibility coefficient of the
common carotid artery and plasma intact parathyroid hormone (iPTH)
levels in renal transplant recipients (N 5 54, r 5 20.37, P < 0.01).
Table 5. Stepwise multiple regression analysis between the end
diastolic diameter of the common carotid artery (dependent variable)
and age, mean arterial blood pressure, plasma iPTH, serum calcium,
ionized serum calcium, serum creatinine, blood hemoglobin levels, body
mass index, duration of hypertension prior to hemodialysis therapy as
well as the hemodialysis period (independent variables) in renal
transplant recipients (N 5 54)
Parameters dependent variable: end
diastolic diameter b P value
Variables in the equation
Age 0.47 0.0002
Serum creatinine level 0.30 0.0129
Variables not in the equation
Parathyroid hormone level 0 0.2802
Serum calcium level 0 0.7962
Ionized serum calcium level 0 0.2744
Blood hemoglobin level 0 0.4915
Mean arterial pressure 0 0.3809
Body mass index 0 0.1888
Duration of hypertension prior to
hemodialysis therapy
0 0.2173
Hemodialysis period 0 0.5209
Beta is standard regression coefficient.
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increased vessel diameter when compared with healthy
controls [1, 9, 10]. In hemodialysis patients it has been
shown that arterial enlargement can be attributed to
chronic volume and flow overload [9]. The observed signif-
icant relationship between serum creatinine levels and end
diastolic diameter of the common carotid artery may also
be related to fluid overload in renal transplant recipients
with lower kidney function. However, arterial stiffening
with increasing age and in hypertension is also associated
with arterial dilation [6, 7]. Most patients with end-stage
renal failure develop hypertension, and high blood pressure
has been suggested as the main cause of reduced arterial
distensibility [1]. In the present study the end diastolic
diameter of the common carotid artery was not different
between renal transplant recipients with secondary hyper-
parathyroidism and with normal plasma iPTH levels. De-
spite an unchanged vessel diameter the distensibility coef-
ficient of the common carotid artery was significantly
reduced in renal transplant recipients with hyperparathy-
roidism. The data therefore indicate that arterial alter-
ations related to secondary hyperparathyroidism are differ-
ent from those occurring with age and in hypertension.
The decrease of arterial distensibility in renal transplant
recipients with hyperparathyroidism may be related to
structural modifications of the arterial wall. There are
numerous reports of calcification of the vascular media in
hemodialysis patients with secondary hyperparathyroidism
[15–17]. Ibels et al found a pronounced calcification of the
internal elastic lamella and the media ground substance in
patients with end-stage renal failure [18]. The major site of
calcium deposition is on the elastic medial fibers and the
calcium accumulation is likely responsible for the progres-
sive destruction of the integrity of the elastic retaining
network [19]. Recently, Niederhoffer et al showed in an
animal model that elastocalcinosis can induce a destruction
of elastic medial fibers that leads to arterial stiffness [20].
Kawagishi et al showed that intima media thickness of
larger arteries was significantly increased in hemodialysis
patients when compared with healthy controls [21]. In this
study parathyroid hormone levels significantly contributed
to the intima media thickness of the femoral artery. Apart
from structural modifications, changes in arterial wall func-
tion may also contribute to the reduced arterial distensibil-
ity in secondary hyperparathyroidism. Several studies have
shown that parathyroid hormone can increase intracellular
calcium concentration of myocytes and can modify vascular
smooth muscle tone [22, 23]. However, serum calcium
concentrations were not related to arterial distensibility in
the present study. Acute infusion of parathyroid hormone
is associated with arterial dilation and hypotension [24]. On
the contrary, states of prolonged parathyroid hormone
excess can exert different effects on blood vessels and have
been implicated in the generation and maintenance of
hypertension [24, 25]. In the present study blood pressure
levels and history of hypertension were not significantly
different between renal transplant recipients with hyper-
parathyroidism and normal plasma iPTH levels.
Left ventricular hypertrophy can frequently be observed
in hemodialysis patients and in renal transplant recipients
[26–28]. Chronic pressure overload or alterations of aortic
input impedance determinants are principal hemodynamic
factors leading to increased cardiac load and to left ven-
tricular hypertrophy. In hemodialysis patients the correla-
tion between cardiac mass and blood pressure levels ap-
pears to be weak or absent, and most investigators have
failed to demonstrate an involvement of hypertension in
the pathogenesis of left ventricular hypertrophy in hemo-
dialysis patients [29, 30]. On the other hand, a significant
correlation between pulse wave velocity and left ventricular
mass had been demonstrated in hemodialysis patients [8].
Moreover, the extent of left ventricular hypertrophy in
these patients was also directly proportional to the decrease
in carotid distensibility [1]. Secondary hyperparathyroidism
in hemodialysis patients had been implicated in the devel-
opment of “inadequate” left ventricular hypertrophy [31].
Data in the present study indicate that alterations of the
cushioning function of the arterial system in secondary
hyperparathyroidism may contribute to the development of
left ventricular hypertrophy in patients with end-stage renal
failure.
In conclusion, the present study demonstrates that the
distensibility of the common carotid artery is reduced in
renal transplant recipients with hyperparathyroidism. Re-
duced arterial distensibility in hyperparathyroidism was not
related to arterial enlargement, suggesting that hyperten-
sion and of secondary hyperparathyroidism affect arterial
wall function differently. The loss of arterial elasticity in
secondary hyperparathyroidism may contribute to the high
cardiovascular morbidity in patients with end-stage renal
failure.
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